Moderate fish-oil supplementation reverses low-platelet, long-chain n-3 polyunsaturated fatty acid status and reduces plasma triacylglycerol concentrations in British Indo-Asians.
What this study found
Moderate fish-oil supplementation improved lipid-related cardiovascular risk markers and enriched platelet long-chain n-3 status, with no significant ethnicity-by-treatment interaction overall. Compared with olive oil, the fish-oil group had reductions in fasting plasma triacylglycerol (P = 0.002), apo B-48 (P = 0.01), and increases in HDL cholesterol (P = 0.03), plasma alpha-tocopherol (P = 0.02), and platelet EPA (P = 0.0001) and DHA (P = 0.0001), with a decrease in platelet arachidonic acid (P = 0.0001). Indo-Asians showed a greater triglyceride reduction tendency than Europeans…
- Study & population
- Randomized, placebo-controlled intervention in healthy adult Europeans and Indo-Asian Sikhs from Reading and Slough, United Kingdom.
- Intervention
- Four 1 g oral fish-oil capsules daily for 12 weeks, taken with meals, providing 4.0 g fish oil in total including 1.5 g eicosapentaenoic acid (EPA) and 1.0 g docosahexaenoic acid (DHA) per day.
- Key limitation
- The intervention was short term (12 weeks) and relatively small, limiting precision and subgroup inference.
Original abstract
BACKGROUND The mechanisms involved in the increased mortality from coronary artery disease in British Indo-Asians are not well understood. OBJECTIVES This study aimed to investigate whether British Indo-Asian Sikhs have higher plasma triacylglycerol concentrations, lower platelet phospholipid levels, and lower dietary intakes of long-chain n-3 polyunsaturated fatty acids (PUFAs) than do age- and weight-matched Europeans and whether moderate dietary fish-oil intake can reverse these differences. DESIGN A randomized, double-blind, placebo-controlled, parallel, fish-oil intervention study was performed. After a 2-wk run-in period, 44 Europeans and 40 Indo-Asian Sikhs were randomly assigned to receive either 4.0 g fish oil [1.5 g eicosapentaenoic acid (EPA) and 1.0 g docosahexaenoic acid (DHA)] or 4.0 g olive oil (control) daily for 12 wk. RESULTS At baseline, the Indo-Asians had significantly higher plasma triacylglycerol, small dense LDL, apolipoprotein B, and dietary and platelet phospholipid n-6 PUFA values and significantly lower long-chain n-3 PUFAs (EPA and DHA) than did the Europeans. A significant decrease in plasma triacylglycerol, plasma apolipoprotein B-48, and platelet phospholipid arachidonic acid concentrations and a significant increase in plasma HDL concentrations and platelet phospholipid EPA and DHA levels were observed after fish-oil supplementation. No significant effect of ethnicity on the responses to fish-oil supplementation was observed. CONCLUSIONS Moderate fish-oil supplementation contributes to a reversal of lipid abnormalities and low n-3 PUFA levels in Indo-Asians and should be considered as an important, yet simple, dietary manipulation to reduce CAD risk in Indo-Asians with an atherogenic lipoprotein phenotype.